ESR1 and breast cancer: As described previously, genechips data identified that the expression of CHES1 was decreased in ERα-positive cells MCF7 and ERα stably expressing MDA-MB-231 cells when treated with E247; these results indicate a possibility that CHES1 may be regulated by E2-ERα signaling in breast cancer cells.